檢索結果 - Geoffrey I. Shapiro

Refine Results
  1. 1
    Heat Shock Protein 90 Inhibition in Lung Cancer

    Heat Shock Protein 90 Inhibition in Lung Cancer 由 Takeshi Shimamura, Geoffrey I. Shapiro

    出版 2008
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    Cyclin-dependent kinases (cdks) and the DNA damage response: rationale for cdk inhibitor–chemotherapy combinations as an anticancer strategy for solid tumors

    Cyclin-dependent kinases (cdks) and the DNA damage response: rationale for cdk inhibitor–chemotherapy combinations as an anticancer strategy for solid tumors 由 Neil Johnson, Geoffrey I. Shapiro

    出版 2010
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    Influenza virus RNA replication in vitro: synthesis of viral template RNAs and virion RNAs in the absence of an added primer

    Influenza virus RNA replication in vitro: synthesis of viral template RNAs and virion RNAs in the absence of an added primer 由 Geoffrey I. Shapiro, Robert M. Krug

    出版 1988
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Anticancer drug targets: cell cycle and checkpoint control

    Anticancer drug targets: cell cycle and checkpoint control 由 Geoffrey I. Shapiro, J. Wade Harper

    出版 1999
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  5. 5
    Development of Phosphoinositide-3 Kinase Pathway Inhibitors for Advanced Cancer

    Development of Phosphoinositide-3 Kinase Pathway Inhibitors for Advanced Cancer 由 James M. Cleary, Geoffrey I. Shapiro

    出版 2010
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  6. 6
    Influenza virus gene expression: control mechanisms at early and late times of infection and nuclear-cytoplasmic transport of virus-specific RNAs

    Influenza virus gene expression: control mechanisms at early and late times of infection and nuclear-cytoplasmic transport of virus-specific RNAs 由 Geoffrey I. Shapiro, Theodore Gurney, Robert M. Krug

    出版 1987
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Targeting CDK4 and CDK6: From Discovery to Therapy

    Targeting CDK4 and CDK6: From Discovery to Therapy 由 Charles J. Sherr, David Beach, Geoffrey I. Shapiro

    出版 2015
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  8. 8
    Clinical Development of the CDK4/6 Inhibitors Ribociclib and Abemaciclib in Breast Cancer

    Clinical Development of the CDK4/6 Inhibitors Ribociclib and Abemaciclib in Breast Cancer 由 Romualdo Barroso‐Sousa, Geoffrey I. Shapiro, Sara M. Tolaney

    出版 2016
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  9. 9
    Personalized chemotherapy in triple-negative breast cancer: are we ready for prime time?

    Personalized chemotherapy in triple-negative breast cancer: are we ready for prime time? 由 Romualdo Barroso‐Sousa, Geoffrey I. Shapiro, Sara M. Tolaney

    出版 2019
    獲取全文
    Carta
    加到收藏夾
    Saved in:
  10. 10
    Combined Depletion of Cell Cycle and Transcriptional Cyclin-Dependent Kinase Activities Induces Apoptosis in Cancer Cells

    Combined Depletion of Cell Cycle and Transcriptional Cyclin-Dependent Kinase Activities Induces Apoptosis in Cancer Cells 由 Dongpo Cai, Vaughan M. Latham, Xinxin Zhang, Geoffrey I. Shapiro

    出版 2006
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    p16<sup><i>INK4A</i></sup> Participates in a G<sub>1</sub> Arrest Checkpoint in Response to DNA Damage

    p16<sup><i>INK4A</i></sup> Participates in a G<sub>1</sub> Arrest Checkpoint in Response to DNA Damage 由 Geoffrey I. Shapiro, Christian D. Edwards, Mark E. Ewen, Barrett J. Rollins

    出版 1998
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer

    Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer 由 Panagiotis A. Konstantinopoulos, Raphaël Ceccaldi, Geoffrey I. Shapiro, Alan D. D’Andrea

    出版 2015
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  13. 13
    Inhibition of influenza viral mRNA synthesis in cells expressing the interferon-induced Mx gene product

    Inhibition of influenza viral mRNA synthesis in cells expressing the interferon-induced Mx gene product 由 Robert M. Krug, Michael W. Shaw, B Broni, Geoffrey I. Shapiro, Otto Haller

    出版 1985
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    MicroRNA-Mediated Suppression of the TGF-β Pathway Confers Transmissible and Reversible CDK4/6 Inhibitor Resistance

    MicroRNA-Mediated Suppression of the TGF-β Pathway Confers Transmissible and Reversible CDK4/6 Inhibitor Resistance 由 Liam Cornell, Seth A. Wander, Tanvi H. Visal, Nikhil Wagle, Geoffrey I. Shapiro

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Biomarker-Guided Development of DNA Repair Inhibitors

    Biomarker-Guided Development of DNA Repair Inhibitors 由 James M. Cleary, Andrew J. Aguirre, Geoffrey I. Shapiro, Alan D. D’Andrea

    出版 2020
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  16. 16
    The Aurora Kinase Inhibitor VX-680 Induces Endoreduplication and Apoptosis Preferentially in Cells with Compromised p53-Dependent Postmitotic Checkpoint Function

    The Aurora Kinase Inhibitor VX-680 Induces Endoreduplication and Apoptosis Preferentially in Cells with Compromised p53-Dependent Postmitotic Checkpoint Function 由 Farid Gizatullin, Yao Yao, Victor Kung, Matthew W. Harding, Massimo Loda, Geoffrey I. Shapiro

    出版 2006
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Personalized Tumor Response Assessment in the Era of Molecular Medicine: Cancer-Specific and Therapy-Specific Response Criteria to Complement Pitfalls of RECIST

    Personalized Tumor Response Assessment in the Era of Molecular Medicine: Cancer-Specific and Therapy-Specific Response Criteria to Complement Pitfalls of RECIST 由 Mizuki Nishino, Jyothi P. Jagannathan, Katherine M. Krajewski, Kevin OʼRegan, Hiroto Hatabu, Geoffrey I. Shapiro, Nikhil H. Ramaiya

    出版 2012
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  18. 18
    First-in-Human Phase I Dose Escalation Study of a Second-Generation Non-Ansamycin HSP90 Inhibitor, AT13387, in Patients with Advanced Solid Tumors

    First-in-Human Phase I Dose Escalation Study of a Second-Generation Non-Ansamycin HSP90 Inhibitor, AT13387, in Patients with Advanced Solid Tumors 由 Geoffrey I. Shapiro, Eunice L. Kwak, Bruce J. Dezube, Murray Yule, John Ayrton, John F. Lyons, Daruka Mahadevan

    出版 2014
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells

    Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells 由 Neil F. Johnson, J. Bentley, L-Z Wang, David R. Newell, Craig Robson, Geoffrey I. Shapiro, Nicola J. Curtin

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer

    A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer 由 Anthony W. Tolcher, Leonard J. Appleman, Geoffrey I. Shapiro, Alain C. Mita, Frank Cihon, Arthur Mazzu, P. R. Sundaresan

    出版 2010
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: